Clinical Trial: Efficacy and Safety of Xinyi Powder in Patients With Allergic Rhinitis and the Lung Deficiency and Cold Syndrome

U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07899515) titled 'Efficacy and Safety of Xinyi Powder in Patients With Allergic Rhinitis and the Lung Deficiency and Cold Syndrome' on Oct. 14.

Brief Summary: By observing the improvement of Xinyi Powder powder and simulated agent on the symptoms, symptom and sign scores, nasal symptom VAS scores, and quality of life of patients with allergic rhinitis due to lung deficiency and cold, the clinical efficacy of Xinyi Powder in the treatment of allergic rhinitis due to lung deficiency and cold is evaluated. It fully embodies the characteristics and advantages of traditional Chinese medicine treatment, provides new treatment methods for the clinical treat...